4//SEC Filing
Stenhouse Mark 4
Accession 0001209191-22-032588
CIK 0001783183other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:50 PM ET
Size
5.5 KB
Accession
0001209191-22-032588
Insider Transaction Report
Form 4
Stenhouse Mark
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-25+15,000→ 15,000 totalExercise: $7.40Exp: 2032-05-24→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001734751
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:50 PM ET
- Size
- 5.5 KB